Skip to content

Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger

Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger . A Randomized Controlled Study

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07569289
Enrollment
164
Registered
2026-05-06
Start date
2026-06-01
Completion date
2028-04-01
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Infertility, Poor responders, IVF-ET, HCG, GnRH agonist, Double trigger

Brief summary

The aim of this randomized controlled study is to compare the efficacy of double trigger protocol \[ the co-administration of GnRH agonist with HCG ( 38 - 39 and 35 - 36 h prior to ovum pick-up, respectively \] with HCG in triggering ovulation in patients with expected poor response to ovarian stimulation

Interventions

Triptorelin (0.2 mg/S.C ) and HCG (10000 IU/I.M) are administered 38 to 39 h and 35 to 36 h prior to ovum pick-up., respectively.

HCG (10000 IU/I.M) is administered 35 to 36 h prior to ovum pick-up.

Sponsors

Bedaya Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* POSEIDON group 3 and 4 * GnRH antagonist IVF cycle

Exclusion criteria

* Hypogonadotrophic hypogonadism * Endometriosis * History of recurrent abortion

Design outcomes

Primary

MeasureTime frameDescription
Metaphase-II oocytes rateTen to fifteen days after starting ovarian stimulationNumber of MII oocyte/ number of cumulus oocyte complex

Secondary

MeasureTime frameDescription
Clinical pregnancy rateFive weeks after embryo transferPresence of intrauterine gestational sac detected by transvaginal ultrasound
Ongoing pregnancy RateEighteen weeks after embryo transferPregnancies continued beyond 20 weeks gestation

Countries

Egypt

Contacts

CONTACTUsama M Fouda, Prof.
umfrfouda@yahoo.com+201095401375

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026